East Tallinn Central Hospital is a hospital located in Tallinn, Estonia in the Veerenni subdistrict, on Ravi 18 street.

During the past decade, East Tallinn Central Hospital conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 31 clinical trials were completed, i.e. on average, 66% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 20 clinical trials were completed. i.e. 125% of trials that started reached the finish line.

Out of the total clinical trials conducted in "East Tallinn Central Hospital" #1 sponsor was "Amgen" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Sylentis, S.A." with 4 trials sponsored and "Grifols Therapeutics LLC" with 4 trials sponsored. Other sponsors include 45 different institutions and companies that sponsored additional 46 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "East Tallinn Central Hospital" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "BeiGene, Ltd." with 1 trials as a collaborator, "ClinPhone, Inc." with 1 trials as a collaborator and "Connect for Children" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "East Tallinn Central Hospital" are "Psoriatic Arthritis" (4 trials), "Atrial Fibrillation" (3 trials), "Multiple Sclerosis" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Ulcerative Colitis" (3 trials). Many other conditions were trialed in "East Tallinn Central Hospital" in a lesser frequency.

Most popular intervention types in "East Tallinn Central Hospital" are "Drug" (55 trials), "Biological" (10 trials), "Other" (8 trials), "Device" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Cisplatin" (3 trials), "Guselkumab" (3 trials), "IGIV-C" (3 trials) and "Adalimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "East Tallinn Central Hospital" are 57 trials for "All" genders, 8 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "East Tallinn Central Hospital". undefined are not yet recruiting, 7 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in East Tallinn Central Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in East Tallinn Central Hospital, 3 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 39 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".

East Tallinn Central Hospital has several departments that took part in Clinical trials: "East Tallinn Central Hospital Center of Oncology" - 4 trials, "East Tallinn Central Hospital; Clinic of Internal Medicine" - 4 trials, "East Tallinn Central Hospital; Neurology Department" - 2 trials, "East Tallinn Central Hospital Ltd., Surgery Clinic, Centre of Urology" - 2 trials